Lipopolysaccharide structure and serum sensitivity of non-serogroupable Neisseria meningitidis
- PMID: 3119854
Lipopolysaccharide structure and serum sensitivity of non-serogroupable Neisseria meningitidis
Abstract
Bactericidal activities of normal human serum for non-serogroupable strains of Neisseria meningitidis were determined. In similar experiments with isolates of Neisseria gonorrhoeae from localized infections, strains with group I lipopolysaccharide (LPS) were uniformly serum resistant and those with group II were serum sensitive. We found no similar association between serum sensitivity of the meningococcal strains and their lipopolysaccharide groups determined by the same pyocin typing system used to classify the gonococcal isolates. Immune mouse sera raised against non-serogroupable meningococci of either LPS group I or II were bactericidal for non-serogroupable strains of the same LPS group and also cross-reactive for strains of the opposite group. They were not bactericidal for the majority (13/17) of the serogroupable strains tested. These findings suggest there are antigens, in addition to the LPS and capsules, that elicit some of the "natural" bactericidal antibodies to pathogenic meningococci.
Similar articles
-
Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits.Vaccine. 2005 Oct 17;23(43):5045-54. doi: 10.1016/j.vaccine.2005.06.011. Vaccine. 2005. PMID: 16046037
-
Blood groups and susceptibility to gonococcal infection. II. The relationship of lipopolysaccharide type to gonococcal sensitivity to the bactericidal activity of normal human serum.J Clin Lab Immunol. 1983 May;11(1):27-32. J Clin Lab Immunol. 1983. PMID: 6410072
-
Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens.Vaccine. 2004 Feb 17;22(7):898-908. doi: 10.1016/j.vaccine.2003.11.036. Vaccine. 2004. PMID: 15040943
-
Meningococcal surrogates of protection--serum bactericidal antibody activity.Vaccine. 2005 Mar 18;23(17-18):2222-7. doi: 10.1016/j.vaccine.2005.01.051. Vaccine. 2005. PMID: 15755600 Review.
-
The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis.Mol Immunol. 1999 Sep-Oct;36(13-14):915-28. doi: 10.1016/s0161-5890(99)00114-5. Mol Immunol. 1999. PMID: 10698346 Review.